Endosialin

BE0010752ProteinHumansCD248

Cell surface glycoprotein involved in various biological processes including angiogenesis, immune response modulation, and tissue remodeling and repair. It is acted on by 1 drug in DrugBank.

Gene name
CD248
UniProtKB entry
Q9HCU0Swiss-Prot
Cellular location
Membrane
Residues / weight
757 residues · 80,858 Da
Also known as
CD164L1 · TEM1 · Tumor endothelial marker 1

Resolves to

Protein
UniProtQ9HCU0UniProt nameCD248_HUMAN
Gene
HGNCHGNC:18219NCBI Gene57124GeneCardsCD248
Pharmacology
KEGGhsa:57124
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
4Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
8GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Endosialin, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In